Regulating the activity of BLVR and its ability to form such complexes may block the activation of Erk1/2 upstream, offering a novel approach to slow the growth of tumor cells with hyper-activated Erk1/2 or to treat any other inflammatory disease related to its activation (83, 181). The gene discussed is MAPK3; the disease is neoplasm.